FdaApplication
NDA 021004
Identifiers
- fda_app_no: NDA021004
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE |
| application_type | NDA |
| approval_date | 1998-12-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPIVIR-HBV | LAMIVUDINE | 5MG/ML | SOLUTION;ORAL |
1 product